Anbio Biotechnology (NNNN)
4.76
+0.14
(+3.03%)
USD |
NASDAQ |
Oct 09, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
Anbio Biotechnology Price : 4.76 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 4.81 | 4.81 | 4.55 | 4.62 | 34710.00 |
| Oct 07, 2026 | 4.76 | 4.99 | 4.721 | 4.90 | 36757.00 |
| Oct 06, 2026 | 4.89 | 5.150 | 4.69 | 4.90 | 52838.00 |
| Oct 05, 2026 | 5.60 | 5.60 | 4.66 | 4.83 | 108902.0 |
| Oct 02, 2026 | 6.17 | 6.17 | 5.54 | 5.55 | 27372.00 |
| Oct 01, 2026 | 6.34 | 6.43 | 6.160 | 6.29 | 12646.00 |
| Sep 30, 2026 | 6.07 | 6.33 | 5.90 | 6.30 | 26791.00 |
| Sep 29, 2026 | 6.08 | 6.240 | 6.01 | 6.16 | 43145.00 |
| Sep 28, 2026 | 6.25 | 6.60 | 6.01 | 6.09 | 29720.00 |
| Sep 25, 2026 | 6.15 | 6.36 | 5.95 | 6.30 | 60286.00 |
| Sep 24, 2026 | 6.09 | 6.76 | 6.035 | 6.15 | 114579.0 |
| Sep 23, 2026 | 5.56 | 6.95 | 5.505 | 6.06 | 636315.0 |
| Sep 22, 2026 | 5.69 | 5.72 | 5.46 | 5.58 | 230224.0 |
| Sep 21, 2026 | 5.30 | 5.80 | 5.30 | 5.68 | 250947.0 |
| Sep 18, 2026 | 5.64 | 5.66 | 5.13 | 5.25 | 290238.0 |
| Sep 17, 2026 | 5.43 | 5.81 | 5.27 | 5.60 | 299843.0 |
| Sep 16, 2026 | 5.54 | 5.77 | 5.42 | 5.58 | 278134.0 |
| Sep 15, 2026 | 6.06 | 6.16 | 5.25 | 5.51 | 275047.0 |
| Sep 14, 2026 | 6.28 | 6.395 | 6.06 | 6.11 | 307732.0 |
| Sep 11, 2026 | 6.49 | 6.49 | 6.21 | 6.34 | 268767.0 |
| Sep 10, 2026 | 6.32 | 6.51 | 6.132 | 6.51 | 242831.0 |
| Sep 09, 2026 | 6.37 | 6.51 | 6.13 | 6.47 | 259535.0 |
| Sep 08, 2026 | 6.50 | 6.79 | 6.20 | 6.48 | 254356.0 |
| Sep 04, 2026 | 6.58 | 6.77 | 6.36 | 6.54 | 231146.0 |
| Sep 03, 2026 | 6.84 | 6.93 | 6.28 | 6.60 | 226580.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CureVac NV | 4.66 |
| PAION AG | 0.01 |
| Epigenomics AG | 1.12 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alkermes Plc | 40.64 |
Price Related Metrics
| Market Cap | 208.92M |